Efficacy and safety of regdanvimab in patients with mild to moderate COVID19: A rapid review and meta‐analysis

B Amani, B Amani - British Journal of Clinical Pharmacology, 2023 - Wiley Online Library
… and mortality rate in patients with COVID-19.Regarding the lack of comprehensive …
COVID-19, this study is aimed to evaluate the efficacy and safety of regdanvimab in COVID-19

… phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19

E Nicastri, F Marinangeli, E Pivetta, E Torri… - …, 2022 - thelancet.com
… for Coronavirus Disease-2019 (COVID-19) … mild to moderate outpatient COVID-19 and
prevent clinical progression. Raloxifene was found as a promising molecule to treat COVID-19

Real-world efficacy of regdanvimab on clinical outcomes in patients with mild to moderate COVID-19

T Kim, DH Joo, SW Lee, J Lee, SJ Lee… - Journal of clinical …, 2022 - mdpi.com
… criteria defined in the Response Guidelines of COVID-19 by the Korean MOHW (version 10)
… A total of 166 patients with mild to moderate COVID-19 were enrolled in this study. Among …

Efficacy and safety of ensitrelvir in patients with mild-to-moderate coronavirus disease 2019: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study

H Mukae, H Yotsuyanagi, N Ohmagari… - Clinical Infectious …, 2023 - academic.oup.com
… As the risk of severe COVID-19 increases with age [32], the safety and efficacy of
ensitrelvir in a wide range of patients with COVID-19 will be further assessed in the phase 3, …

Efficacy and safety of Xiyanping injection in the treatment of COVID19: A multicenter, prospective, open‐label and randomized controlled trial

XY Zhang, L Lv, YL Zhou, LD Xie, Q Xu… - Phytotherapy …, 2021 - Wiley Online Library
… label trial involving adult patients hospitalized with mild to moderated COVID-19, we provided
up to now the first clinical evidence that XYP injection is a safe treatment and is effective in …

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

FP Polack, SJ Thomas, N Kitchin… - New England journal …, 2020 - Mass Medical Soc
… of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in
a BNT162b2 recipient. The safety profile of BNT162b2 was characterized by short-term, mild-…

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

A Cortegiani, G Ingoglia, M Ippolito, A Giarratano… - Journal of critical …, 2020 - Elsevier
… … had demonstrated marked efficacy and acceptable safety in treating COVID-19 associated
… The suggested target population ranged from patients with mild respiratory symptoms and …

[HTML][HTML] Efficacy and safety of inhaled ciclesonide in treating patients with asymptomatic or mild COVID-19 in the RACCO trial: protocol for a multicenter, open-label …

J Terada-Hirashima, M Suzuki… - JMIR Research …, 2020 - researchprotocols.org
… to assess its efficacy and safety in treating patients with COVID-19. This prospective … to
investigate the efficacy and safety of ciclesonide in treating patients with COVID-19 during the …

[HTML][HTML] Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: a systematic review and meta-analysis

M Liu, Y Gao, Y Yuan, K Yang, S Shi, J Tian… - Integrative medicine …, 2021 - Elsevier
mild or ordinary COVID-19. … efficacy and safety of LH treatment of patient with COVID-19.
The results of this study have certain reference value for the treatment of patients with COVID-19

[PDF][PDF] Efficacy of Molnupiravir for the treatment of mild or moderate COVID-19 in adults: a meta-analysis

K Benaicha, RR Khenhrani, M Veer, S Devi… - Cureus, 2023 - cureus.com
efficacy of molnupiravir among mild or moderate COVID-19 … were “Molnupiravir,” “COVID-19,”
and “efficacy.” This meta-… the effectiveness of molnupiravir with a placebo for COVID-19